These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21937912)
1. Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease. Tanji K; Mori F; Kito K; Kakita A; Mimura J; Itoh K; Takahashi H; Kamitani T; Wakabayashi K J Neuropathol Exp Neurol; 2011 Oct; 70(10):879-89. PubMed ID: 21937912 [TBL] [Abstract][Full Text] [Related]
2. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Tanji K; Mori F; Mimura J; Itoh K; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2010 Aug; 120(2):145-54. PubMed ID: 20339856 [TBL] [Abstract][Full Text] [Related]
3. The role of NUB1 in α-synuclein degradation in Lewy body disease model mice. Tanji K; Miki Y; Maruyama A; Mori F; Mimura J; Itoh K; Kamitani T; Wakabayashi K Biochem Biophys Res Commun; 2016 Feb; 470(3):635-642. PubMed ID: 26797281 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy. Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501 [TBL] [Abstract][Full Text] [Related]
6. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356 [TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice. Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925 [TBL] [Abstract][Full Text] [Related]
8. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468 [TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476 [TBL] [Abstract][Full Text] [Related]
10. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Schulz-Schaeffer WJ Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819 [TBL] [Abstract][Full Text] [Related]
11. Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers. Umeda T; Hatanaka Y; Sakai A; Tomiyama T Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445158 [TBL] [Abstract][Full Text] [Related]
12. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner. Taguchi K; Watanabe Y; Tsujimura A; Tanaka M Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073 [TBL] [Abstract][Full Text] [Related]
13. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Ihara M; Yamasaki N; Hagiwara A; Tanigaki A; Kitano A; Hikawa R; Tomimoto H; Noda M; Takanashi M; Mori H; Hattori N; Miyakawa T; Kinoshita M Neuron; 2007 Feb; 53(4):519-33. PubMed ID: 17296554 [TBL] [Abstract][Full Text] [Related]
14. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels. Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models. Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537 [TBL] [Abstract][Full Text] [Related]
16. α-synuclein phosphorylation and truncation are normal events in the adult human brain. Muntané G; Ferrer I; Martinez-Vicente M Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575 [TBL] [Abstract][Full Text] [Related]
17. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients. Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582 [TBL] [Abstract][Full Text] [Related]
18. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226 [TBL] [Abstract][Full Text] [Related]
19. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases. Dalfó E; Ferrer I Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629 [TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]